The kynuramine oxidative deamination assay was utilized to evaluate the monoamine oxidases inhibitory effects of compounds 1–4, 7, 9 and 12–14 at concentrations of 0.001–100 μM for MAO-A and 0.01–100 μM for MAO-B (Chaurasiya et al., 2016). The assay is based on tracking and monitoring the MAO catalyzed conversion of kynuramine to 4-hydroxy quinolone fluorometrically. The conditions of the assay were optimized following the previously published procedure (Larit et al., 2018). The oxidized fluorescent product of kynuramine (4-hydroxyquinoline) was assessed at λem 380 nm and λex 320 nm following the published procedure using the SoftMax Pro program (Parikh et al., 2002). The standard inhibitors phenelzine, clorgyline, and deprenyl were used at a concentration range of 0.001 μM to 100 μM with the aid of XL-Fit© software.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.